CREATINE KINASE-MB RAPIDTEST - COFEPRIS Registration 362R2022 SSA
Access comprehensive regulatory information for CREATINE KINASE-MB RAPIDTEST (CREATINE KINASE-MB RAPIDTEST) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 362R2022 SSA and manufactured by DIINSEL, S.A. DE C.V.. The device was registered on May 12, 2022.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
ELDISPOSITIVOCREATINEKINASE-MBRAPIDTESTESUNINMUNOENSAYO CROMATOGRÁFICO RÁPIDO PARA LADETECCIÓNCUALITATIVADELACREATININAQUINASAMBHUMANAENSANGRECOMPLETA,SUEROOPLASMACOMOAYUDA EN EL DIAGNÓSTICO DE INFARTO DE MIOCARDIO (IM).
THE CREATINEKINASE-MBRAPIDTEST DEVICE IS A RAPID CHROMATOGRAPHIC IMMUNOASSAY FOR THE QUALITATIVE DETECTION OF HUMAN AMBIN CREATININE KINASE IN WHOLE BLOOD, SERUM OR PLASMA AS AN AID IN THE DIAGNOSIS OF MYOCARDIAL INFARCTION (MI).